A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
作者信息
Zeidner Joshua F, Lin Tara L, Vigil Carlos E, Fine Gil, Yair Levy M, Nazha Aziz, Esteve Jordi, Lee Daniel J, Yee Karen, Dalovisio Andrew, Wang Eunice S, Bergua Burgues Juan M, Schriber Jeffrey, Litzow Mark R, Frankfurt Olga, Castillo Teresa Bernal Del, Bhatt Vijaya Raj, Bhatnagar Bhavana, Mehta Priyanka, Dillon Richard, Vicente Maria Vidriales, Anthony Stephen, Bearss David, Montesinos Pau, Douglas Smith B
机构信息
University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
University of Kansas Medical Center, Kansas City, KS, USA.
出版信息
Blood Cancer J. 2021 Oct 30;11(10):175. doi: 10.1038/s41408-021-00568-3.
Abstract
摘要
Zotero 插件